Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
7.49
Jul 28 • 3:57 PM ET Dollar change+0.03 Percentage change(0.33%)
Aftermarket Close
7.59
Aftermarket • 5:28 PM ET Dollar change+0.10 Percentage change(1.27%)
Index
-
Market Cap
73.40M
Enterprise Value
84.96M
Income
-43.72M
Sales
21.19M
Book/sh
8.55
Cash/sh
2.07
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
165
IPO
Apr 09, 2013
P/E
-
Forward P/E
-
PEG
-
P/S
3.46
P/B
0.88
P/C
3.62
P/FCF
-
EV/EBITDA
-
EV/Sales
4.01
Quick Ratio
2.60
Current Ratio
3.04
Debt/Eq
0.51
LT Debt/Eq
0.50
Option/Short
No / Yes
EPS (ttm)
-10.58
EPS next Y
-1.94
EPS next Q
-1.22
EPS this Y
63.32%
EPS next Y
47.65%
EPS next 5Y
53.24%
EPS past 3/5Y
41.57% 38.06%
Sales past 3/5Y
-6.84% 24.17%
EPS Y/Y TTM
40.02%
Sales Y/Y TTM
-24.41%
EPS Q/Q
78.90%
Sales Q/Q
-17.30%
Insider Own
20.36%
Insider Trans
0.73%
Inst Own
8.68%
Inst Trans
1.43%
ROA
-29.81%
ROE
-47.96%
ROIC
-34.78%
Gross Margin
56.55%
Oper. Margin
-163.06%
Profit Margin
-206.29%
SMA20
5.73%
SMA50
3.57%
SMA200
-24.45%
Trades
Shs Outstand
9.79M
Shs Float
7.80M
52W High
17.74 -57.76%
52W Low
5.84 28.24%
Volatility
13.98% 9.60%
ATR (14)
0.67
RSI (14)
55.10
Beta
1.09
Rel Volume
0.66
Avg Volume
12.52K
Volume
8,219
Perf Week
7.07%
Perf Month
6.61%
Perf Quarter
1.01%
Perf Half Y
-34.25%
Perf YTD
-34.14%
Perf Year
-40.05%
Perf 3Y
-89.98%
Perf 5Y
-97.45%
Perf 10Y
-99.57%
Prev Close
7.47
Price
7.49
Change
0.33%
Date Action Analyst Rating Change Price Target Change
Jan-29-25Downgrade TD Cowen Buy → Hold $2 → $1
May-13-22Upgrade Alliance Global Partners Neutral → Buy $8.75
Apr-22-21Initiated Cowen Outperform $31
Mar-23-21Initiated Stifel Buy $30
Feb-25-21Initiated Cantor Fitzgerald Overweight $35
Feb-01-21Downgrade Alliance Global Partners Buy → Neutral $15.60 → $22.25
Aug-17-20Initiated Aegis Capital Buy $25
Aug-29-17Initiated Aegis Capital Buy $3.50
May-09-16Initiated Rodman & Renshaw Buy $12
Jul-22-26 08:00AM
Jul-16-26 07:30AM
Jul-13-26 07:30AM
Jul-06-26 07:30AM
Jul-02-26 07:30AM
07:30AM Loading…
Jun-30-26 07:30AM
Jun-29-26 07:00AM
Jun-08-26 08:00AM
May-26-26 08:00AM
May-13-26 07:01PM
06:30AM
May-04-26 08:30AM
Apr-20-26 08:00AM
Apr-13-26 08:00AM
Mar-19-26 03:04PM
12:47PM Loading…
12:47PM
06:30AM
Mar-18-26 09:23AM
Mar-11-26 08:30AM
Mar-10-26 08:00AM
Mar-03-26 08:00AM
Feb-26-26 06:45PM
Feb-24-26 09:40AM
Jan-21-26 08:00AM
Dec-10-25 08:00AM
Dec-04-25 08:00AM
Dec-02-25 08:00AM
Nov-24-25 08:00AM
Nov-13-25 04:01PM
07:45AM
06:30AM Loading…
06:30AM
Nov-12-25 09:15AM
08:30AM
07:32AM
Nov-10-25 05:30PM
Nov-06-25 08:30AM
Nov-04-25 08:20AM
Oct-16-25 08:57AM
Oct-14-25 09:55AM
Oct-13-25 08:30AM
Oct-06-25 07:30AM
Sep-25-25 07:23AM
06:00AM
Sep-22-25 07:00AM
Sep-02-25 07:30AM
Aug-25-25 08:00AM
Aug-13-25 05:46PM
09:21AM
Aug-12-25 03:00PM
06:30AM
Aug-07-25 06:50PM
Aug-05-25 08:30AM
Aug-04-25 05:20PM
Jul-30-25 06:05PM
Jun-26-25 08:30AM
Jun-24-25 08:30AM
May-15-25 03:11AM
May-14-25 07:40AM
06:30AM
May-08-25 08:30AM
May-07-25 05:50PM
08:30AM
May-01-25 08:30AM
Apr-21-25 08:30AM
Apr-17-25 08:30AM
Apr-08-25 08:30AM
Mar-24-25 12:00PM
10:59AM
Mar-17-25 08:30AM
08:30AM
Mar-11-25 03:01AM
Mar-10-25 09:43AM
06:30AM
Mar-07-25 08:30AM
Mar-05-25 08:30AM
Mar-04-25 08:30AM
Feb-27-25 08:30AM
Feb-08-25 02:39AM
Feb-07-25 08:08AM
Jan-30-25 08:45AM
Jan-21-25 08:30AM
Jan-17-25 01:14PM
Jan-14-25 12:09PM
08:30AM
Nov-21-24 08:30AM
Nov-08-24 06:02AM
Nov-07-24 07:40AM
06:30AM
Nov-04-24 08:30AM
Oct-30-24 08:30AM
Oct-23-24 08:30AM
Oct-17-24 08:30AM
Oct-15-24 08:30AM
Oct-09-24 05:35PM
Oct-08-24 09:09AM
Oct-02-24 12:00PM
Oct-01-24 08:30AM
Sep-12-24 08:30AM
Sep-10-24 08:30AM
Aug-08-24 07:45AM
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
CEO & DirectorMr. Erez Raphael
CFOMs. Chen Franco-Yehuda
Co-Founder & Production ChiefDov Oppenheim
Chief Operations OfficerLara Dodo
VP of Accounting & Corporate DevelopmentZoe Harrison
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Matheis DennisDirectorJul 23 '26Buy6.9314,430100,00043,026Jul 28 05:27 PM
Nelson Steven CharlesPresident and CCOAug 27 '25Buy0.5340,00021,20095,000Aug 27 04:30 PM
Last Close
0.9144
Jul 28 • 3:59 PM ET Dollar change+0.0110 Percentage change(1.22%)
Aftermarket Close
0.9270
Aftermarket • 7:36 PM ET Dollar change+0.0126 Percentage change(1.38%)
LUCD Lucid Diagnostics Inc daily Stock Chart
Index
RUT
Market Cap
185.68M
Enterprise Value
194.73M
Income
-58.18M
Sales
5.13M
Book/sh
-0.04
Cash/sh
0.14
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
82
IPO
Oct 14, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
36.20
P/B
-
P/C
6.66
P/FCF
-
EV/EBITDA
-
EV/Sales
37.96
Quick Ratio
1.03
Current Ratio
1.07
Debt/Eq
6.70
LT Debt/Eq
0.17
Option/Short
No / Yes
EPS (ttm)
-0.47
EPS next Y
-0.17
EPS next Q
-0.05
EPS this Y
44.96%
EPS next Y
26.76%
EPS next 5Y
29.61%
EPS past 3/5Y
23.61% -25.34%
Sales past 3/5Y
131.97% -
EPS Y/Y TTM
60.80%
Sales Y/Y TTM
23.03%
EPS Q/Q
67.79%
Sales Q/Q
51.69%
Insider Own
21.22%
Insider Trans
0.57%
Inst Own
18.31%
Inst Trans
2.10%
ROA
-134.61%
ROE
-710.60%
ROIC
-958.70%
Gross Margin
-48.38%
Oper. Margin
-959.64%
Profit Margin
-1133.21%
SMA20
-8.18%
SMA50
-9.27%
SMA200
-19.95%
Trades
Shs Outstand
164.88M
Shs Float
159.97M
52W High
1.63 -43.88%
52W Low
0.90 1.60%
Volatility
4.65% 6.38%
ATR (14)
0.06
RSI (14)
40.92
Beta
1.09
Rel Volume
0.58
Avg Volume
1.39M
Volume
812,628
Perf Week
-5.41%
Perf Month
-15.33%
Perf Quarter
-13.74%
Perf Half Y
-25.66%
Perf YTD
-16.11%
Perf Year
-16.11%
Perf 3Y
-33.26%
Perf 5Y
-
Perf 10Y
-
Prev Close
0.90
Price
0.91
Change
1.22%
Date Action Analyst Rating Change Price Target Change
Dec-27-21Initiated Ascendiant Capital Markets Buy $16
Nov-08-21Initiated Needham Buy $17
Nov-08-21Initiated Cantor Fitzgerald Overweight $21
Nov-08-21Initiated BTIG Research Buy $14
May-15-26 08:00AM
May-14-26 07:01PM
05:12PM
08:00AM
May-13-26 09:19AM
08:31AM Loading…
May-01-26 08:31AM
Apr-30-26 08:31AM
Apr-24-26 10:23AM
Apr-23-26 08:30AM
Apr-09-26 08:01AM
Apr-02-26 08:01AM
Mar-30-26 08:00AM
Mar-26-26 03:01PM
01:13PM
08:00AM
09:18AM Loading…
Mar-25-26 09:18AM
Mar-12-26 09:01AM
Mar-03-26 08:15AM
Feb-26-26 09:55AM
Feb-25-26 08:05PM
Feb-24-26 09:40AM
Feb-11-26 09:22PM
Feb-04-26 08:01AM
Jan-22-26 09:23AM
Jan-21-26 11:22AM
08:00AM
Dec-30-25 09:01AM
Dec-24-25 07:45AM
Dec-09-25 08:01AM
Nov-20-25 08:15AM
04:02PM Loading…
Nov-13-25 04:02PM
08:15AM
08:00AM
Nov-12-25 04:03PM
09:15AM
08:00AM
Nov-11-25 07:34AM
Nov-10-25 08:15AM
Nov-06-25 06:05PM
Nov-05-25 06:50PM
Oct-29-25 08:01AM
Oct-16-25 12:00PM
Oct-15-25 08:01AM
Oct-10-25 01:25PM
Sep-25-25 08:01AM
Sep-16-25 08:01AM
Sep-11-25 09:17AM
Sep-10-25 08:00AM
Sep-09-25 04:01PM
Sep-05-25 09:16AM
Aug-27-25 08:00AM
Aug-26-25 08:01AM
Aug-14-25 08:00AM
03:09AM
Aug-13-25 09:15AM
08:00AM
Aug-12-25 03:00PM
09:35AM
Aug-07-25 06:55PM
Aug-05-25 09:15AM
08:00AM
Jul-30-25 05:10PM
08:01AM
Jul-16-25 07:31AM
Jun-18-25 12:01PM
May-27-25 07:31AM
May-15-25 08:01AM
03:12AM
May-14-25 09:15AM
08:01AM
May-13-25 08:15AM
May-12-25 05:15PM
May-07-25 10:00AM
May-05-25 08:10AM
May-01-25 08:31AM
Apr-30-25 08:31AM
Apr-24-25 08:01AM
Apr-21-25 05:01PM
Apr-11-25 09:23AM
Apr-09-25 07:24PM
04:01PM
Apr-03-25 09:00AM
Mar-27-25 08:01AM
Mar-26-25 03:01AM
Mar-25-25 11:15PM
08:01AM
Mar-24-25 12:17PM
09:10AM
08:01AM
Mar-21-25 10:38PM
Mar-20-25 08:31AM
Mar-18-25 08:31AM
Mar-13-25 07:36AM
Mar-10-25 09:01AM
Mar-05-25 04:45PM
Mar-04-25 08:25AM
Feb-27-25 08:31AM
Feb-25-25 08:31AM
Feb-20-25 08:31AM
Feb-18-25 08:30AM
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.
Chairman & CEODr. Lishan Aklog M.D.
President & COOMr. Shaun M. O'Neill M.B.A.
Chief Financial OfficerMr. Dennis M. McGrath CPA
General Counsel & SecretaryMr. Michael Adam Gordon
Ph.D.Dr. Sanford D. Markowitz M.D.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Matheis DennisDirectorMay 20 '26Buy1.00245,000245,2701,033,443May 21 04:20 PM
Matheis DennisDirectorAug 20 '25Buy1.02100,000101,840665,443Aug 22 05:17 PM